ArticleInvestigational new drugs2013
Bortezomib overcomes MGMT-related resistance of glioblastoma cell lines to temozolomide in a schedule-dependent manner.
Panagiotis J Vlachostergios et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this paperpooled ittrialcites it